Survey to Assess Why People Are Not Responding to Treatment in Hypertension

• Status: Completed
• Trial end date: 2010-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will describe the factors influencing the physician in face of elevated blood pressure in already treated patients

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Collaborator: International Clinical Trials Association
• Treatments: Telmisartan

Criteria

Inclusion Criteria:

• Men or women over 18

• Hypertensive patients

• Uncontrolled hypertension (blood pressure >/=140/90 mmHg on the day of consultation or >/=130/80 mmHg in diabetic patients or in patients suffering from kidney failure, or in elderly patients with a systolic blood pressure >/=150 mmHg (in the absence of orthostatic hypotension)

• Patients treated with a combination, fixed or not, of Renin-Angiotensin System Blocker (RASB) + Hydrochlorothiazide (HCTZ)

• Patients examined in common medical care practice, whatever the reason for consultation

• Patients informed of the study